SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-022517
Filing Date
2021-09-13
Accepted
2021-09-13 12:06:25
Documents
51
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 461343
2 ex31-1.htm EX-31.1 11447
3 ex31-2.htm EX-31.2 11467
4 ex32-1.htm EX-32.1 4451
  Complete submission text file 0001493152-21-022517.txt   2899089

Data Files

Seq Description Document Type Size
5 INLINE XBRL INSTANCE DOCUMENT vicp-20200930.xml EX-101.INS 429961
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vicp-20200930.xsd EX-101.SCH 34082
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vicp-20200930_cal.xml EX-101.CAL 47018
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vicp-20200930_def.xml EX-101.DEF 149382
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vicp-20200930_lab.xml EX-101.LAB 250957
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vicp-20200930_pre.xml EX-101.PRE 210863
Mailing Address 1735 BUFORD HIGHWAY STE. 215-113 CUMMING GA 30041
Business Address 1735 BUFORD HIGHWAY STE. 215-113 CUMMING GA 30041 470-514-4013
Vicapsys Life Sciences, Inc. (Filer) CIK: 0001468639 (see all company filings)

IRS No.: 621153426 | State of Incorp.: FL
Type: 10-Q | Act: 34 | File No.: 000-56145 | Film No.: 211249085
SIC: 2834 Pharmaceutical Preparations